No Data
No Data
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
GSK Reaches Confidential Settlement in Illinois Zantac Litigation
GSK (GSK) Price: 38.92, Change: +0.27, Percent Change: +0.71
Express News | GSK Issues Statement Regarding The Zantac (Ranitidine) Litigation; Has Reached A Confidential Settlement With Martin Gross; GSK Does Not Admit Any Liability In This Settlement
GSK: Case Is Related to Ranitidine Litigation
GSK: Case Is Related to Ranitidine Litigation
GSK Will Continue to Vigorously Defend Itself, Manage Litigation in Best Interests of Group, Shareholders
GSK Will Continue to Vigorously Defend Itself, Manage Litigation in Best Interests of Group, Shareholders
Statement: Zantac (Ranitidine) Litigation – Gross Case
GSK plc (LSE/NYSE: GSK) has reached a confidential settlement with Martin Gross resolving the case he filed in Illinois state court. GSK does not admit any liability in this settlement. The case will